Why the study?
This review aims to discuss the rationale behind percutaneous LAAC devices for atrial fibrillation patients ineligible for long-term anticoagulation, examine the evolution of devices and techniques, and explore current understanding of its potential and limitations in stroke prevention.
Does percutaneous left atrial appendage closure prevent stroke in atrial fibrillation patients ineligible for long-term anticoagulation?
Does percutaneous left atrial appendage closure prevent stroke in atrial fibrillation patients ineligible for long-term anticoagulation?
This review highlights that LAAC is a viable stroke prevention strategy for high-risk AF patients who cannot tolerate long-term anticoagulation, while emphasizing the need to monitor for peri-device leaks and thrombus.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: